Gene · 9782
Papers1,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AURKB-driven dissolution of CIZ1-RNA assemblies from the inactive X chromosome in mitosis. | Nucleic Acids Res | 2026 | 41626693 | PubTator, text mining | PubMed |
| Congenital Coarctation of the Aorta in a Patient With ROBO4 c.695C>T (p.Thr232Met) Germline Variant. | Ann Intern Med Clin Cases | 2026 | 41613935 | PubTator, text mining | PubMed |
| Decoding innate lymphoid cell heterogeneity and plasticity in colorectal cancer. | Clin Transl Med | 2026 | 41527493 | PubTator, text mining | PubMed |
| Deciphering ALS-linked genetic variants in indian patients using targeted and exome sequencing approaches. | Amyotroph Lateral Scler Frontotemporal Degener | 2026 | 41137727 | PubTator, text mining | PubMed |
| Exploring Molecular Mechanism of Ferroptosis in A549 Lung Cancer Cells. | Tanaffos | 2025 | 42757385 | PubTator, text mining | PubMed |
| Xist in X chromosome inactivation: mechanisms and disease relevance. | Cell Commun Signal | 2025 | 41430272 | PubTator, text mining | PubMed |
| Natural degradation of RNA polymerase II is essential for oocyte chromatin reorganization and maternal-to-zygotic transition. | Nat Commun | 2025 | 41387441 | PubTator, text mining | PubMed |
| [Overlap of neuropathy and myopathy genes: convergence of two entities]. | Med Sci (Paris) | 2025 | 41313053 | PubTator, text mining | PubMed |
| Innovative Strategies for the Targeted Degradation of Viral Proteins: Paving the Way for Next-Generation Therapeutics. | Pharmaceutics | 2025 | 41304758 | PubTator, text mining | PubMed |
| Spheres, worms, and packing problems in the nanoscale assembly of ALS-linked protein Matrin-3. | Mol Cell | 2025 | 41043388 | PubTator, text mining | PubMed |
| A Case of Amyotrophic Lateral Sclerosis With Coexisting Maturity-onset Diabetes of the Young Type 5. | JCEM Case Rep | 2025 | 41018173 | PubTator, text mining | PubMed |
| Matrin-3 forms spherical and wormlike assemblies that are modulated by RNA binding and ALS/FTD-associated mutations. | Mol Cell | 2025 | 40975059 | PubTator, text mining | PubMed |
| RNA binding proteins potentially regulate alternative splicing of immune-related genes during the progression of coronary artery disease. | Exp Biol Med (Maywood) | 2025 | 40950552 | PubTator, text mining | PubMed |
| Identifying Therapeutic Targets for Amyotrophic Lateral Sclerosis Through Modeling of Multi-Omics Data. | Int J Mol Sci | 2025 | 40806220 | PubTator, text mining | PubMed |
| Sex-dependent epigenetic disruption of YY1 binding by prenatal BPA exposure downregulates Matr3 and alters Agap1 splicing in the offspring hippocampus. | Biol Sex Differ | 2025 | 40790242 | PubTator, text mining | PubMed |
| Corrigendum to "Matrin3 stimulates IFITM1 expression to negatively regulate hepatitis B virus RNA levels" [Int. J. Biol. Macromol. Vol. 319, Part 1, August 2025, 145277]. | Int J Biol Macromol | 2025 | 40721365 | PubTator, text mining | PubMed |
| 5-methylcytosine regulated CCNL2 promotes tumorigenesis and cisplatin resistance of ovarian cancer with therapeutic implications. | J Ovarian Res | 2025 | 40707993 | PubTator, text mining | PubMed |
| ALS-associated RNA-binding proteins promote UNC13A transcription through REST downregulation. | EMBO J | 2025 | 40707625 | PubTator, text mining | PubMed |
| A role for the spinal cord cholinergic neuron circadian clock in RNA metabolism and mediating ALS disease phenotypes. | bioRxiv | 2025 | 40667180 | PubTator, text mining | PubMed |
| DDX1 methylation mediated MATR3 splicing regulates intervertebral disc degeneration by initiating chromatin reprogramming. | Nat Commun | 2025 | 40610464 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9782/papers?page=2